MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2025 International Congress

    Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

    K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)

    Objective: To evaluate the potential benefits of a post-injection telehealth follow-up visit for people with craniofacial dystonia. Background: Craniofacial dystonias, including blepharospasm and oromandibular dystonia,…
  • 2025 International Congress

    Delayed Diagnosis of Cervical Dystonia: A Case Report Highlighting the Importance of an on-time Specialist Evaluation

    A. Lysandropoulos (Durham, USA)

    Objective: To present a case of cervical dystonia misdiagnosed as anxiety disorder for five years, emphasizing the critical need for timely recognition and appropriate treatment…
  • 2025 International Congress

    Dystonia in Cameroon: Clinical characteristic and treatment patterns

    HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo (Douala, Cameroon)

    Objective: To describe the clinical characteristics and treatment patterns of dystonia in a cohort of Cameroonian patients. Background: Dystonia is a complex and heterogeneous movement…
  • 2025 International Congress

    Pontine Hemorrhage leading to Bilateral Olivary Degeneration and Cervical Dystonia

    M. Iqbal, C. Tarolli, D. Manou (Rochester, USA)

    Objective: We describe a case of a 66-year-old woman who developed cervical dystonia with dystonic tremor and hypertrophic olivary degeneration (HOD) after a right pontine…
  • 2024 International Congress

    Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

    M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)

    Objective: To examine the disparities in utilization of botulinum toxin (BoNT) injections for patients with cervical dystonia (CD) within the United States Medicare population. Background:…
  • 2024 International Congress

    Perceptions of Diseases in Patients with Cervical Dystonia

    D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, M. Patel, M. Moreno-Escobar, A. Murray, A. Memon, J. Frey (Morgantown, USA)

    Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…
  • 2024 International Congress

    Botulinum Toxin and Deep Brain Stimulation in Dystonia

    J. Souza, A. Falcone, R. Barbosa, M. Soares, R. Munhoz, M. Farah, T. Capato, S. Casagrande, M. Cordellini, G. Micheli, J. Limongi, E. Barbosa, C. Listik, R. Cury (Sao Paulo, Brazil)

    Objective: The primary outcome was the relationship between BoNT dosage and DBS surgery in each muscle. A secondary analysis of BoNT dosages through different muscle…
  • 2024 International Congress

    Do Lower Doses of Botulinum Neurotoxin Type-A Offer a Longer Duration of Effect and Superior Efficacy in Patients with Cervical Dystonia?

    A. Kundrick, H. Fernandez (Cleveland, USA)

    Objective: To determine if there is a difference in efficacy and duration of effect between high-dose and low-dose botulinumtoxin neurotoxin type-A for cervical dystonia. Background:…
  • 2024 International Congress

    Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

    A. Ellenbogen, R. Hauser, A. Patel, P. Mcallister, D. Vitarella, T. Gross, R. Kazerooni, C. Gallagher, D. Hollander (Farmington Hills, USA)

    Objective: To assess the residual therapeutic efficacy of prior botulinum toxin (BoNT) injection at the patient-desired retreatment interval in cervical dystonia (CD). Background: BoNT injections…
  • 2024 International Congress

    Efficacy and Safety of DaxibotulinumtoxinA-lanm for Injection in Adults with Cervical Dystonia: Pooled Global Analysis of ASPEN-1 and ASPEN-1-CN

    D. Truong, H. Xingyue, A. Ellenbogen, J. Lingjing, K. Dashtipour, A. Patel, T. Gross, R. Kazerooni, C. Gallagher, F. Xiaojin, S. Yunan, G. Lei, W. Xinhua, D. Hollander (Riverside, USA)

    Objective: To evaluate the pooled efficacy and safety of 2 doses of DaxibotulinumtoxinA-lanm for injection (DAXI) for the treatment of cervical dystonia (CD) in 2…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley